MCHX 3.85 Marchex Inc $MCHX Hit a 52 week low of 3.15

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
MCHX 3.85 Marchex Inc $MCHX Hit a 52 week low of 3.15 Closing the day 11/06/14 at 3.85 +0.06 +1.58% With a day low of 3.15 and a total volume of 742,313.

MCHX Recent Posts: http://investorshangout.com/Marchex-MCHX-54715/

MCHX Marchex Inc Recent Headline News

Marchex posts 3Q loss
Automated Insights - Thu Nov 06, 4:04AM CST
SEATTLE (AP) _ Marchex Inc. (MCHX) on Thursday reported a loss of $21.5 million in its third quarter.
MCHX: 3.85 (+0.06)

Marchex Announces Third Quarter 2014 Results and Announces Share Repurchase Program
Business Wire - Wed Nov 05, 3:16PM CST
Marchex, Inc. (NASDAQ:MCHX), a mobile advertising technology company, today announced its financial results for the third quarter ended September 30, 2014.
MCHX: 3.85 (+0.06)

Marchex to Report Third Quarter 2014 Results on November 5
Business Wire - Wed Oct 22, 8:01AM CDT
Marchex, Inc. (NASDAQ:MCHX) today announced that it will release financial results for its third quarter 2014 ended on September 30, 2014, on November 5, 2014 at approximately 4:15 p.m. ET. At that time, Marchex will post the press release on the Press Center section of its corporate website (www.marchex.com/company/press).
MCHX: 3.85 (+0.06)

Marchex Announces Regular Quarterly Dividend for Common Stock
Business Wire - Fri Oct 17, 8:00AM CDT
Marchex, Inc. (NASDAQ:MCHX), today announced that the company's Board of Directors has declared a regular quarterly dividend in the amount of $0.02 per share on its common stock. Marchex will pay these dividends on November 18, 2014 to the holders of record as of the close of business on November 7, 2014. As of October 17, 2014, 5,232,636 shares of Class A common stock and 37,612,422 shares of Class B common stock are outstanding.
MCHX: 3.85 (+0.06)

Marchex Launches Mobile Advertising Measurement and Click-to-Call Breakthrough; Real-Time Call DNA Reveals Customer Insights Without Recording Phone Calls
Business Wire - Wed Oct 15, 7:01AM CDT
Marchex Inc. (NASDAQ:MCHX), a mobile advertising technology company, today launched Real-Time Call DNA, a major advancement to its call analytics platform. For the first time, advertisers will be able to visually map, analyze, and measure what happens inside a phone conversation after a consumer calls their business - without recording any of the actual dialogue.
MCHX: 3.85 (+0.06)

Consulting CFO Mark Wasowicz Joins vcfo in Seattle
PRWeb - Fri Oct 10, 8:04AM CDT
vcfo, a leading professional services firm offering financial, recruiting and human resource solutions, announced that Mark Wasowicz has joined the firm as a Consulting CFO. Based in Seattle, Mark will provide strategic leadership and Chief Financial Officer level support to vcfo clients in all regions. Mark has more than 20 years of experience as a financial professional and operational development strategist, and he has worked with companies in a variety of industries, including healthcare, advertising, retail, IT, computer software and more.
MCHX: 3.85 (+0.06)

Marchex, Inc. (MCHX) in Focus: Stock Moves 5.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Sep 24, 8:18AM CDT
Marchex, Inc. (MCHX) was a big mover last session, as the company saw its shares rise by nearly 6% on the day.
INUV: 1.48 (+0.10), BIDU: 236.90 (-0.80), FB: 75.26 (+0.43), MCHX: 3.85 (+0.06)

4 Breakout Stocks Under $10 for Your Trading Radar
at The Street - Wed Sep 24, 6:08AM CDT
These under-$10 stocks are within range of triggering breakout trades.
FRM: 6.22 (-0.27), AEY: 2.50 (+0.07), MCHX: 3.85 (+0.06), HIMX: 7.77 (-0.13)

Auto Dealerships Failing to Capture Customers Over the Phone, New Marchex Data Shows
Business Wire - Tue Sep 23, 7:01AM CDT
When consumers search for cars, parts or auto services on their mobile phones and call up a dealership, one in six times their call doesn't get answered, meaning dealerships lose out on scores of potentially high-margin leads just by failing to answer the phone, according to new data released today from Marchex, Inc. (NASDAQ:MCHX), a mobile advertising technology company.
MCHX: 3.85 (+0.06)

Nasdaq stocks posting largest volume increases
AP - Fri Sep 19, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
CNQR: 128.05 (+0.11), ELOS: 9.79 (-0.01), EMKR: 5.18 (+0.02), EVBS: 6.30 (+0.01), MSON: 14.24 (+0.12), VVUS: 3.41 (+0.11), HSON: 3.51 (+0.19), RPRX: 6.45 (+0.03), PFBX: 12.94 (-0.05), MCHX: 3.85 (+0.06)

Oracle and Concur are big market movers
AP - Fri Sep 19, 3:40PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
DRC: 81.73 (+0.06), CLR: 52.96 (-0.59), CAG: 34.75 (+0.38), VVUS: 3.41 (+0.11), SNE: 19.70 (-0.48), JBLU: 12.81 (+0.68), COL: 83.98 (+0.04), ORCL: 39.81 (+0.52), RAD: 5.35 (+0.16), CNQR: 128.05 (+0.11), TIBX: 23.50 (+0.20), PIR: 13.24 (+0.28), RHT: 60.74 (+1.15), MCHX: 3.85 (+0.06)

Downgrade Alert for Marchex (MCHX)
Comtex SmarTrend(R) - Fri Sep 19, 6:54AM CDT
Marchex (NASDAQ:MCHX) was downgraded from Outperform to Market Perform at BMO Capital today. The stock closed yesterday at $4.07 on volume of 10.4 million shares, above average daily volume of 303,000. Marchex (NASDAQ:MCHX) has potential upside of 284.9% based on a current price of $4.07 and analysts' consensus price target of $15.67. The stock should find initial resistance at its 50-day moving average (MA) of $9.82 and further resistance at its 200-day MA of $10.21.
MCHX: 3.85 (+0.06)

Market Maker Surveillance Report. MCHX, PIR, SCOK, RPRX, SINO, RWLK, Losing Stocks With Lowest Price Friction For Thursday, September 18th 2014
M2 - Fri Sep 19, 4:03AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 4944 companies with "abnormal" market making, 2520 companies with positive Friction Factors and 2350 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Thursday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Marchex Inc (NASDAQ:MCHX), Pier 1 Imports Inc (NYSE IR), Sinocoking Coal And Coke Chemical Industries Inc (NASDAQ:SCOK), Repros Therapeutics Inc (NASDAQ:RPRX), Sino-Global Shipping America Ltd (NASDAQ:SINO), (NASDAQ:RWLK). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
SCOK: 3.33 (+0.02), PIR: 13.24 (+0.28), RWLK: 29.98 (-0.02), RPRX: 6.45 (+0.03), MCHX: 3.85 (+0.06), SINO: 2.14 (+0.24)

Why Marchex (MCHX) Stock Is Plummeting Today
at The Street - Thu Sep 18, 10:25AM CDT
Marchex (MCHX) is falling Thursday after lowering its call-driven revenue for the rest of the 2014.
MCHX: 3.85 (+0.06)

Investors look to Lighten Up on Shares of Marchex, Shares Down 43.6% (MCHX)
Comtex SmarTrend(R) - Thu Sep 18, 10:07AM CDT
Marchex (NASDAQ:MCHX) is one of today's worst performing low-priced stocks, down 43.6% to $4.23 on 20.2x average daily volume. Marchex has traded 6.0 million shares thus far today, vs. average volume of 300,000 shares per day. The stock has underperformed the Dow (-43.6% to the Dow's 0.5%) and underperformed the S&P 500 (-43.6% to the S&P's 0.4%) during today's trading.
MCHX: 3.85 (+0.06)

Marchex Updates 2014 Guidance
Business Wire - Thu Sep 18, 5:00AM CDT
Marchex, Inc. (NASDAQ:MCHX), a mobile advertising technology company, today announced it is updating its outlook for the remainder of 2014.
MCHX: 3.85 (+0.06)

Marchex Down 15.2% Since SmarTrend Downtrend Call (MCHX)
Comtex SmarTrend(R) - Tue Sep 16, 9:10AM CDT
SmarTrend identified a Downtrend for Marchex (NASDAQ:MCHX) on August 12th, 2014 at $9.61. In approximately 1 month, Marchex has returned 15.19% as of today's recent price of $8.15.
MCHX: 3.85 (+0.06)

Marchex to Present at the Deutsche Bank 2014 Technology Conference
Business Wire - Wed Sep 03, 8:01AM CDT
Marchex, Inc. (NASDAQ:MCHX) today announced that Russell Horowitz, Chief Executive Officer, will participate in a fireside chat at the following conference:
DB: 30.62 (-0.30), MCHX: 3.85 (+0.06)

Marchex Inc. (MCHX) Stock Research Links

MCHX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Updated Category News Views 92

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 651

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Updated Category News Views 117

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

Continue Reading
RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

Updated Category News Views 258

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

Continue Reading
BioSyent Inc. Announces Quarterly Dividend for Shareholders

Updated Category News Views 132

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...

Continue Reading